| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/26/2004 | EP1421942A1 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 05/26/2004 | EP1421938A1 Antitumor agents and process for producing the same |
| 05/26/2004 | EP1421936A1 Potassium channel opener |
| 05/26/2004 | EP1421934A1 Remedial agent for arthrosis deformans |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421182A1 Methods of inducing differentiation of stem cells |
| 05/26/2004 | EP1421180A2 Method of treating systemic inflammatory response syndrome |
| 05/26/2004 | EP1421113A1 Methods of screening based on the egf receptor crystal structure |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421110A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421089A1 4-THIOXO-4,7-DIHYDRO-THIENO 2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS |
| 05/26/2004 | EP1421088A1 4-thioxo-4,7-dihydro-thieno 2,3-b]pyridine-5-carbothioamides as antiviral agents |
| 05/26/2004 | EP1421087A1 Diazacycloalkanes as oxytocin agonists |
| 05/26/2004 | EP1421086A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/26/2004 | EP1421083A1 Novel imidazopyridine compounds with therapeutic effect |
| 05/26/2004 | EP1421078A1 Beta-3 adrenergic agonists |
| 05/26/2004 | EP1421077A2 Novel pyrazole analogs acting on cannabinoid receptors |
| 05/26/2004 | EP1421075A1 Piperidine derivatives useful as ccr5 antagonists |
| 05/26/2004 | EP1421074A1 Novel compounds |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421067A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/26/2004 | EP1421065A1 Hydrazinopeptoids and their uses for treating cancers |
| 05/26/2004 | EP1420826A2 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420795A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 05/26/2004 | EP1420794A1 Prostaglandin analogs as chloride channel opener |
| 05/26/2004 | EP1420793A1 Method and composition for treatment of ocular hypertension and glaucoma |
| 05/26/2004 | EP1420790A1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine |
| 05/26/2004 | EP1420788A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420775A1 Platinum complexes and their use in cancer treatment |
| 05/26/2004 | EP1420773A1 Amidine derivatives for treating amyloidosis |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420770A1 Photoreactive compounds and compositions |
| 05/26/2004 | EP1420760A2 Aerosolized decongestants for the treatment of sinusitis |
| 05/26/2004 | EP1420646A1 Antimicrobial agent |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1328269B1 Association of a cb1 receptor antagonist and sibutramin for treating obesity |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1218402B1 Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1206474B1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/26/2004 | EP1206446B1 Carboxylic acid amides, their production and their use as drugs |
| 05/26/2004 | EP1161226B1 Phosphocholine linked prodrug derivatives |
| 05/26/2004 | EP1150705B1 Protection of cells with bbi in connection with treatment with chemical agents |
| 05/26/2004 | EP1124815B1 Method for producing luteolin and luteolin derivatives |
| 05/26/2004 | EP1123110A4 Compositions and methods for promoting tissue repair using heat shock proteins |
| 05/26/2004 | EP1098873B1 Alpha-(2-hydroxyphenyl)nitrone compounds, pharmaceutical compositons containing the same and their use for treating inflammation |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP0971710B1 Use of chelerythrine and radiation for tumor therapy |
| 05/26/2004 | EP0968194B1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | EP0786253B1 Antitumor composition comprising ascorbic acid and metal complexes of (na)phthalocyanines |
| 05/26/2004 | EP0778768B1 Formulations and methods for providing prolonged local anesthesia |
| 05/26/2004 | EP0561977B1 Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke |
| 05/26/2004 | CN1500147A Improved gene expression |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1499982A Use of Il-18 inhibitors for treatment and/or prevention of heart disease |
| 05/26/2004 | CN1499971A Novel use of arylethene sulfonamide derivative |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
| 05/26/2004 | CN1499958A Medical aerosol formulations |
| 05/26/2004 | CN1498898A Minor peptide of growth factor receptor KDR of specific combined blood vessel endothelium |
| 05/26/2004 | CN1498657A Immunity growth substance for animal and its prepn. method |
| 05/26/2004 | CN1498648A Aloe capsule and tablet for anoxia resistant and prepn. method |
| 05/26/2004 | CN1498623A Glycyrrhizic acid and its derivative used as RANTES inducer |
| 05/26/2004 | CN1151258C Prodn. of erythropoietin by endogenous gene activation |
| 05/26/2004 | CN1151156C Novel xanthone compounds, their preparation and use as medicament |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
| 05/26/2004 | CN1151147C Indole derivatives as 5-HT receptor antagonist |
| 05/26/2004 | CN1151144C Benzopyans and benzothiopyrans as RAR selective retinoid agonists |
| 05/26/2004 | CN1151140C Glucokinase activators |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1150918C Medicine containing active components of Panax japonicum foot and preparing process |
| 05/26/2004 | CN1150916C Fish medicine for preventing fish from raising nose above water |
| 05/26/2004 | CN1150904C Pharmaceutical compositions for oral administration of molecular iodine |
| 05/26/2004 | CN1150900C Pharmaceutical compositions for oral administration, comprising active substance and cyclodextrin |
| 05/26/2004 | CN1150898C Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthrits, neurodermatitis and regional enterits |
| 05/26/2004 | CN1150897C Injectable composition of non-steroidal anti-inflammatory drugs |
| 05/26/2004 | CN1150895C Dry Powder for inhalation |
| 05/26/2004 | CN1150890C Medicinal aerosol formulations |
| 05/26/2004 | CN1150887C Foot lotion compsn. |
| 05/26/2004 | CN1150878C Washing agent composition |
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
| 05/25/2004 | US6740772 Pgd2 agonists; sleep inducing action; intracerebral transition; stability |
| 05/25/2004 | US6740770 Crystal of bicalutamide and production method thereof |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |